Law / United States / Colorado

Colorado pharmacies: access to prescription drug label information for patients who have difficulty seeing or reading standard labels

C.R.S. section 12-280-124(4) (as added by HB 24-1115)

In force since .

An accessibility requirements rule binding private bodies.

Instrument type
an act of a legislature
Obligation class
Disclosure

What it requires

  • If you are a pharmacy, when you dispense a prescription drug to a patient (or the patient's caretaker) who notifies you of difficulty seeing or reading standard printed labels on the container, provide a method to access the label information required by section 12-280-124(1) to (3), by the patient's choice of an electronic label affixed to the container that transmits the label information, directions and written instructions to the patient's external accessible device (including a compatible prescription drug reader), a prescription drug reader provided at no cost, a label in braille or large print, or another method in the United States Access Board's best practices for access to prescription drug labeling information; this applies on and after (C.R.S. 12-280-124(4)(b)).
  • You comply if you offer the patient an alternative method and the State Board of Pharmacy affirms that it is substantially similar to the method the patient requested and meets the patient's needs (C.R.S. 12-280-124(4)(c)).
  • If a patient requests a method of access you have not yet been asked to provide to any other patient, take no more than twenty-eight days to comply, and make reasonable efforts to ensure patient safety and access in the meantime (C.R.S. 12-280-124(4)(d)).
  • Make good faith, sustained, periodic and reasonable efforts to inform the public that prescription drug label information is available in accessible formats for individuals who have difficulty seeing or reading standard printed labels (C.R.S. 12-280-124(4)(e)).
  • Otherwise follow the United States Access Board's best practices for pharmacies in providing independent access to prescription drug label information (C.R.S. 12-280-124(4)(f)).

These lines are LexLint's reading of the law's text.

What this law does

Drafted with AI

Drafted with AI from the cited sources under the direction of UnGovr staff. UnGovr holds editorial responsibility for this page. How this site is made

Research summary

Legal information, not legal advice. This is LexLint's own research summary of a public legal source, and it creates no attorney-client relationship. For decisions that matter, consult qualified counsel in the relevant jurisdiction. About LexLint

On and after , a pharmacy dispensing a prescription drug to a patient who notifies it of difficulty seeing or reading standard printed labels must provide the patient with a method to access the label information, chosen by the patient from an electronic label that transmits the information to the patient's external accessible device, a prescription drug reader provided at no cost, a braille or large print label, or another method in the best practices of the United States Access Board.

A pharmacy that offers a patient an alternative method of access complies if the State Board of Pharmacy affirms that the method is substantially similar to the method the patient requested and meets the patient's needs. If a patient requests a method of access that the pharmacy has not yet been asked to provide to any other patient, the pharmacy must not take more than twenty-eight days to comply.

Pharmacies must make good faith, sustained, periodic, and reasonable efforts to inform the public that prescription drug label information is available in accessible formats.

Back to the example  ·  Lint your app

Page updated .